Pick one
Retatrutide is more aggressive mechanistically
Documentation may vary depending on production timelines
It has a defensible rationale slower escalation of an area-postrema-active agent is the standard lever for gastrointestinal tolerability but it should not be described as the clinical titration schedule, because it is not

Repeating the above steps according to the amino acid sequence Fmoc-Thr (tBu) -OH, Fmoc-Asn (Trt) -OH, Fmoc-Ser (tBu) -OH, Fmoc-Gly-OH, Fmoc-Val-OH, Fmoc-Asn (Trt) -OH, Fmoc-Thr (tBu) -OH, Fmoc-Pro-OH, Fmoc-Leu-OH, Fmoc-Ile-OH, Fmoc-Pro-OH, Fmoc-Gly-OH, Fmoc-Phe-OH, Fmoc-Asn Trt-OH, (Fmoc-Asn Trt) -OH, Fmoc-Ser-Ser (Pro-me) -OH, Fmoc-His (Trt) -OH, Fmoc-Arg (Fmoc) -OH, Fmoc-Leu-OH, Fmoc-Phe-OH, Fmoc-Ser-Ser (Pro-me) -OH, Fmoc-me-OH, Fmoc-Pro-OH, Fmoc-Leu-OH, Fmoc-Phe-OH, Fmoc-Pro-OH, Fmoc-Pro-OH, Fmoc-Ser-OH, Fmoc-Ser-Ser, and/Pro-Ser-Ser, and/Pro-Ser-Ser, and/Pro-Ser-Ser, and P-Ser-Ser, Fmoc-Glu (OtBu) -OH, Fmoc-Ala-OH, Fmoc-Leu-OH, Fmoc-Arg (Pbf) -OH, Fmoc-Gln (Trt) -OH, Fmoc-Ala-Thr (pro-me-me) -OH, Fmoc-Cys (Trt) -OH, Fmoc-Thr-OH, Fmoc-Ala-OH, Fmoc-Thr (tBu) -OH, Fmoc-Asn (Trt) -OH, Fmoc-Cys (Trt) -OH, Fmoc-Lys (Boc) -OH, Fmoc-Glu-OtBu, Eicoside acid 1